MEMORANDUM AND ORDER
Plaintiffs Alcon Laboratories, Inc. and Alcon Manufacturing, Ltd. (collectively “Alcon”) filed this action against defendants Pharmacia Corporation and Phar-macia & Upjohn Company (collectively “Pharmacia”) and the Trustees of Columbia University (“Columbia”), seeking a declaratory judgment that their glaucoma treatment product, marketed under the brand-name Travatan, does not infringe on U.S. Patent No. 4,599,353 (the “ ’353 patent”) and that the ’353 patent is invalid. The ’353 patent, which was issued in 1986, is owned by Columbia and exclusively licensed to Pharmacia. It covers the use of prostaglandins for treating glaucoma.
Columbia moves for a protective order quashing a subpoena and precluding the deposition of John P. White, Esq., its lead trial counsel and the lawyer responsible for the prosecution of the ’353 patent for Columbia over twenty years ago. For the reasons set forth below, Columbia’s motion is denied in its entirety.
The Federal Rules of Civil Procedure do not prohibit the deposition of an opposing counsel, yet they are strongly disfavored.
See United States v. Yonkers Bd. of Educ.,
This presumption is based on the recognition that even a deposition of counsel limited to relevant and nonprivileged information risks disrupting the attorney-client relationship and impeding the litigation.... Nevertheless, depositions of opposing counsel are not categorically barred. Rather, the request to depose a party’s attorney must be weighed by balancing, generally speaking, the necessity for such discovery in the circumstances of the case against its potential to oppress the adverse party and to burden the adversary process itself.
Madanes v. Madanes,
Although the Second Circuit has not expressly adopted the
Shelton
standard, it expressed agreement with the principles expressed by the Eighth Circuit.
See Yonkers Bd. of Educ.,
Columbia contends that the practice of deposing opposing party’s attorneys is decried absent some showing of “compelling need,” and that Alcon has failed to satisfy the prerequisite compelling need for White’s deposition established in
Shelton.
Columbia argues that “the mere request to depose a party’s attorney constitutes good cause for obtaining a protective order.”
N.F.A. Corp. v. Riverview Narrow Fabrics,
Alcon responds that
Shelton
is inapplicable here because the Eighth Circuit limited that holding in
Pamida, Inc. v. E.S.
[t]he Shelton test was intended to protect against the ills of deposing counsel in a pending case which could potentially lead to the disclosure of the attorney’s litigation strategy.... But Shelton was not intended to provide heightened protection to attorneys who represented a client in a completed case and then also happened to represent that same client in a pending case where the information known only by the attorneys regarding the prior concluded case was crucial.
Pamida,
Under
Shelton,
Alcon must show that no other means exist to obtain the information it seeks other than to depose opposing counsel, and that the information sought is relevant, non-privileged and crucial to its case.
Shelton,
While an .attorney’s deposition should be precluded when there are other persons available to testify as to the same . information or if interrogatories are available, deposing White is the only practical avenue here.
See, e.g., N.F.A. Corp. v. Riverview Narrow Fabrics, Inc.,
Columbia maintains that the information sought by Alcon is privileged or protected by the attorney work-product doctrine. It argues that much of the information sought concerns White’s mental impressions regarding the prosecution of the ’353 patent, which are inextricably intertwined with his and Columbia’s trial strategies in this and other actions involving the ’353 patent. In support of this argument, Columbia emphasizes that White avers in a declaration that he has no recollection about the information Alcon seeks outside of his involvement as trial counsel in the litigations concerning the ’353 patent. Columbia also disputes that neither its claims nor Dr. Bito’s testimony at deposition, have effectively waived the attorney-client privilege.
“[T]he Court cannot rule in a vacuum, prior to the deposition, that every question to be asked will seek to elicit privileged information.”
In re Arthur Treacher’s Franchisee Litigation,
Moreover, White’s declaration asserting his lack of non-privileged or non-protected information is not dispositive of the issue of whether he should be subject to a deposition, since “[t]here is a basis ... for the position that an attorney cannot avoid a deposition by asserting that he dr she has no relevant, nonprivileged information, and that at a minimum, the attorney must submit to a deposition so that his lack of knowledge may be tested and any claimed privilege placed on the record.”
Niagara Mohawk Power Corp.,
While the Court is mindful of Columbia’s concerns regarding the deposition of its trial counsel in this and several other actions involving the ’353 patent, a patent prosecution attorney cannot avoid being deposed simply because he is later selected to act as trial counsel in an infringement action concerning the very patent he helped to prosecute. The retention of the same counsel to serve as both a prosecuting attorney for its patent and trial counsel in an action involving the validity of that patent presents a Hobson’s choice to any
Further, Columbia presents no evidence, nor has this Court found any, that Alcon subpoenaed White for nefarious reasons. Alcon subpoenaed White because they believe he has personal knowledge of information crucial to its inequitable conduct defense. This lack of bad faith quells many of the fears that routinely plague courts faced with the issue of attorney depositions, and supports the denial of a protective order.
CONCLUSION
Accordingly, Columbia’s motion for a protective order and an order quashing the subpoena directed to John P. White, Esq. is denied.
SO ORDERED:
